| Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome : An international survey of current practice | British journal of haematology | | | 2026 | 6 | 80 |
|
| Single-kidney transplantation with discarded partner kidney vs. Dual kidney transplantation : results from a national cohort study | BMC nephrology | | | 2026 | 7 | 3 |
|
| Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation : A Swiss Transplant Cohort Study analysis | Liver transplantation | | | 2026 | 4 | 18 |
|
| Does early letermovir initiation delay engraftment ? | Antimicrobial agents and chemotherapy | | | 2026 | 3 | 29 |
|
| Pretransplant CMV-IgG Titers and DNAemia Are Associated With CMV Infections Post Allogeneic Hematopoietic Cell Transplant With or Without Letermovir | Open forum infectious diseases | | | 2026 | 3 | 13 |
|
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct | | | 2025 | 19 | 71 |
|
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | | | 2025 | 21 | 181 |
|
| Old Pathogens-New Patient Types : Infections in a CAR T-Cell Recipient. Could It Get Any More Complicated ? | Transplant infectious disease | | | 2025 | 11 | 55 |
|
| The Importance of MRI in the Early Diagnosis of Acute Invasive Fungal Rhinosinusitis | Diagnostics | | | 2025 | 157 | 217 |
|
| Defining bloodstream and central venous catheter-related infections in patients following haematopoietic cell transplantation : position paper of the European Blood and Marrow Transplantation Society Infectious Diseases Working Party and Practice Harmonization and Guidelines Committee | Clinical microbiology and infection | | | 2025 | 8 | 0 |
|
| Blood virome after allogeneic hematopoietic stem cell transplantation | Open forum infectious diseases | | | 2025 | 67 | 134 |
|
| Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation : recommendations from the 10th European Conference on Infections in Leukaemia | The Lancet Infectious Diseases | | | 2025 | 13 | 0 |
|
| Enhancing post-kidney transplant prognostication: an interpretable machine learning approach for longitudinal outcome prediction | npj digital medicine | | | 2025 | 3 | 4 |
|
| Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortality | Bone marrow transplantation | | | 2025 | 9 | 0 |
|
| Pneumonia definition in allogeneic hematopoietic cell transplant recipients : Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee | Current research in translational medicine | | | 2025 | 13 | 39 |
|
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | | | 2025 | 27 | 116 |
|
| Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies : A Case-Control Study | Mycoses | | | 2025 | 12 | 87 |
|
| Management of Clostridioides difficile infection in patients with haematological malignancies and after cellular therapy : guidelines from 10th European Conference on Infections in Leukaemia (ECIL - 10) | EClinicalMedicine | | | 2025 | 9 | 139 |
|
| Population pharmacokinetic analysis of letermovir in adult hematopoietic cell transplant recipients | Antimicrobial agents and chemotherapy | | | 2025 | 13 | 48 |
|
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | | | 2025 | 77 | 234 |
|
| Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe : A systematic review by the European Conference on Infections in Leukemia (ECIL) | The Journal of infection | | | 2025 | 10 | 62 |
|
| Management of Invasive Pulmonary Aspergillosis in Intensive Care Units : Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS) | Mycoses | | | 2025 | 14 | 490 |
|
| Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland | Infection | | | 2025 | 41 | 232 |
|
| Antifungal treatment duration in hematology patients with invasive mold infections : a real-life update | Open forum infectious diseases | | | 2024 | 94 | 125 |
|
| Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients : An Update | Viruses | | | 2024 | 10 | 180 |
|
| Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019) | Infectious diseases and therapy | | | 2024 | 12 | 296 |
|
| Reexploring cytomegalovirus serology in allogeneic hematopoietic cell transplantation | Current opinion in infectious diseases | | | 2024 | 111 | 137 |
|
| Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS) | Open forum infectious diseases | | | 2024 | 87 | 232 |
|
| An Update on Breakthrough Invasive Mold Infections | Mycopathologia | | | 2024 | 10 | 95 |
|
| Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients : results from a pan-European survey | Therapeutic advances in infectious disease | | | 2024 | 9 | 121 |
|
| Clinicopathologic conference : Bloodstream infection in an allogeneic hamatopoietic cell transplant : Thinking beyond the usual | Transplant infectious disease | | | 2024 | 39 | 87 |
|
| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | | | 2024 | 117 | 141 |
|
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | | | 2024 | 115 | 190 |
|
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | | | 2024 | 52 | 112 |
|
| Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients : A multicenter cohort, 2015-2020 | American journal of transplantation | | | 2024 | 34 | 43 |
|
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | | | 2024 | 63 | 264 |
|
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | | | 2024 | 91 | 60 |
|
| Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis | Transplant infectious disease | | | 2024 | 67 | 183 |
|
| Bacterial infections in solid organ transplant recipients | Current opinion in organ transplantation | | | 2024 | 37 | 1 |
|
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | | | 2024 | 86 | 110 |
|
| How I treat : Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients | Transplant infectious disease | | | 2024 | 11 | 152 |
|
| Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients : Recommendations from the EBMT practice harmonization and guidelines committee | Current research in translational medicine | | | 2024 | 58 | 170 |
|
| Invasive aspergillosis in liver transplant recipients in the current era | American journal of transplantation | | | 2024 | 25 | 0 |
|
| Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant | Open forum infectious diseases | | | 2023 | 88 | 135 |
|
| Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities : A Multi-Center Retrospective Study | Journal of Fungi | | | 2023 | 97 | 215 |
|
| 'Which trial do we need ? Culture of preservation fluid in abdominal organ transplant recipients' Author's reply | Clinical microbiology and infection | | | 2023 | 10 | 148 |
|
| Vaccine-preventable infections among solid organ transplant recipients in Switzerland | JAMA network open | | | 2023 | 141 | 182 |
|
| Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients | Clinical infectious diseases | | | 2023 | 106 | 216 |
|
| Antifungal prophylaxis and pre-emptive therapy : when and how ? | Molecular aspects of medicine | | | 2023 | 87 | 66 |
|
| Which trial do we need ? Culture of preservation fluid in abdominal organ transplant recipients | Clinical microbiology and infection | | | 2023 | 10 | 46 |
|
| Duration of antifungal treatment in mold infection : when is enough ? | Current opinion in infectious diseases | | | 2023 | 98 | 117 |
|
| The present and future of blood virome in allogeneic hematopoietic cell transplant recipients | Current opinion in infectious diseases | | | 2023 | 99 | 195 |
|
| Bloodstream infections in allogeneic haematopoietic cell recipients from the swiss transplant cohort study: trends of causative pathogens and resistance rates | Bone marrow transplantation | | | 2023 | 155 | 118 |
|
| American Society for Transplantation and Cellular Therapy Series, #6 : Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients | Transplantation and cellular therapy | | | 2023 | 84 | 284 |
|
| CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients | Open forum infectious diseases | | | 2023 | 143 | 166 |
|
| Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trial | Clinical infectious diseases | | | 2023 | 109 | 226 |
|
| Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial | Clinical infectious diseases | | | 2023 | 152 | 294 |
|
| Invasive Aspergillosis and the Impact of Azole-resistance | Current fungal infection reports | | | 2023 | 73 | 248 |
|
| Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma | Viruses | | | 2023 | 159 | 175 |
|
| Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological Update | Open forum infectious diseases | | | 2023 | 130 | 135 |
|
| Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients | Antimicrobial agents and chemotherapy | | | 2023 | 108 | 496 |
|
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases | | | 2023 | 72 | 124 |
|
| Nouveautés dans la prise en charge de l’infection à cytomégalovirus chez les patients transplantés | Revue médicale suisse | | | 2023 | 100 | 111 |
|
| Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? | Open forum infectious diseases | | | 2022 | 275 | 272 |
|
| Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study | The Journal of infection | | | 2022 | 262 | 336 |
|
| Friends and foes : “The quarrels of friends are the opportunities of foes” | Current opinion in infectious diseases | | | 2022 | 11 | 0 |
|
| Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature review | Swiss medical weekly | | | 2022 | 187 | 94 |
|
| Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals | Open forum infectious diseases | | | 2022 | 238 | 211 |
|
| Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients | Antimicrobial agents and chemotherapy | | | 2022 | 108 | 343 |
|
| Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections | Mycoses | | | 2022 | 308 | 211 |
|
| Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes | American journal of transplantation | | | 2022 | 193 | 158 |
|
| Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/small bowel transplant recipient | Clinical transplantation | | | 2022 | 260 | 0 |
|
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | | | 2022 | 248 | 146 |
|
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | | 2022 | 266 | 151 |
|
| When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients? | Mycoses | | | 2022 | 105 | 101 |
|
| Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study | The Journal of hospital infection | | | 2022 | 259 | 159 |
|
| Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients | American journal of transplantation | | | 2022 | 218 | 163 |
|
| Screening for Parasitic Infection and Tuberculosis in Immunosuppressed and Pre-Immunosuppressed Patients: An Observational Study | Tropical medicine and infectious disease | | | 2021 | 248 | 277 |
|
| COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? | Clinical microbiology and infection | | | 2021 | 241 | 177 |
|
| Progress and current challenges in the management of invasive fungal infections in hematologic malignancy patients and allogeneic hematopoietic cell transplant recipients | | | | 2021 | 345 | 545 |
|
| Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study | Vaccines | | | 2021 | 209 | 324 |
|
| Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study | American journal of transplantation | | | 2021 | 283 | 224 |
|
| Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipients | Immunity, inflammation and disease | | | 2021 | 376 | 245 |
|
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | | | 2021 | 388 | 160 |
|
| Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study | American journal of transplantation | | | 2021 | 156 | 157 |
|
| Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experience | Mycopathologia | | | 2021 | 247 | 325 |
|
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | | | 2021 | 366 | 1 |
|
| Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response | BMC infectious diseases | | | 2021 | 161 | 371 |
|
| Differences between infectious disease events in first liver transplant versus retransplantation in the Swiss Transplant Cohort Study | Liver transplantation | | | 2021 | 147 | 0 |
|
| Editorial: Transplant infectious disease landscape in the COVID19-Era | Current opinion in infectious diseases | | | 2021 | 198 | 0 |
|
| The EHA research roadmap: infections in hematology | HemaSphere | | | 2021 | 235 | 260 |
|
| Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir | Antimicrobial agents and chemotherapy | | | 2021 | 253 | 461 |
|
| Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey | Open forum infectious diseases | | | 2021 | 108 | 148 |
|
| Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantation | Journal of Fungi | | | 2021 | 193 | 156 |
|
| Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study | The journal of antimicrobial chemotherapy | | | 2021 | 217 | 0 |
|
| Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients | Medical mycology | | | 2021 | 171 | 0 |
|
| Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective study | Clinical Infectious Diseases | | | 2020 | 257 | 773 |
|
| Risk factors for candidemia: a prospective matched case-control study | Critical Care | | | 2020 | 388 | 238 |
|
| Response to "Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study" | Blood advances | | | 2020 | 211 | 78 |
|
| Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland | Infection | | | 2020 | 251 | 331 |
|
| First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study | American Journal of Transplantation | | | 2020 | 298 | 164 |
|
| Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain Lesions | Clinical infectious diseases | | | 2020 | 277 | 0 |
|
| Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm | Medical Mycology | | | 2020 | 226 | 372 |
|
| Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases | | | 2020 | 467 | 157 |
|
| First case of Cryptococcus gattii multilobar pneumonia in Switzerland and associated challenges | Swiss Medical Weekly | | | 2020 | 389 | 204 |
|
| Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipient | Transplantation | | | 2020 | 351 | 1 |
|
| Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study | Transplant Infectious Disease | | | 2020 | 409 | 2 |
|
| Prophylaxie antimicrobienne et approches thérapeutiques empiriques et préemptives pour la prévention des infections chez les receveurs de greffe allogénique de cellules hématopoïétiques | | | | 2020 | 592 | 273 |
|
| Infectiologie sur mesure - 1. Immunogénétique des maladies infectieuses : premiers pas | Revue médicale suisse | | | 2019 | 302 | 4 |
|
| National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017 | Euro Surveillance | | | 2019 | 380 | 307 |
|
| Antimicrobial prophylaxis and preemptive approaches for the prevention of infections in the stem cell transplant recipient, with analogies to the hematologic malignancy patient | Infectious disease clinics of North America | | | 2019 | 184 | 622 |
|
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study | Transplant Infectious Disease | | | 2018 | 595 | 0 |
|
| Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy | Haematologica | | | 2018 | 256 | 259 |
|
| Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS) | Clinical Microbiology and Infection | | | 2018 | 332 | 238 |
|
| Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients | Transplant Infectious Disease | | | 2018 | 339 | 222 |
|
| Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study | Transplant Infectious Disease | | | 2018 | 475 | 0 |
|
| Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort | Transplant Infectious Disease | | | 2018 | 387 | 1 |
|
| First case of Candida auris in Switzerland: discussion about preventive strategies | Swiss Medical Weekly | | | 2018 | 510 | 339 |
|
